A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions
Conclusion
Due to the limited data available, famciclovir appears to be a reasonable option in immunocompromised patients with a mild valacyclovir or acyclovir hypersensitivity reaction.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Shah, S. A., Gulbis, A., Wilhelm, K. Tags: Case Reports Source Type: research
More News: Acyclovir | Antiviral Therapy | Cancer & Oncology | Cold Sores | Herpes | Stem Cell Therapy | Stem Cells | Transplants | Valtrex | Zovirax